Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Dizaji Asl, Khadijeh  [Clear All Filters]
2023
Sabetkam S, Kalarestaghi H, Mazloumi Z, Asl KDizaji, Norouzi N, Rafat A. The dysfunction of natural killer cells is essential for the development of type 1 diabetes. Pathol Res Pract. 2023;247:154556.
Khodaei SHassanpour, Sabetkam S, Charoudeh HNozad, Asl KDizaji, Rafat A, Mazloumi Z. The effect of mitochondria inhibition on natural killer cells cytotoxicity in triple-negative breast cancer cells. Eur J Pharmacol. 2023:176106.
Valipour B, Davari S, Farahzadi R, Pourrasol S, Mehran N, Asl KDizaji, Altaha SMansour, Hojjati Z, Charoudeh HNozad. Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells. Cell Biochem Funct. 2023.
2022
Rafat A, Asl KDizaji, Mazloumi Z, Samadirad B, Ashrafianbonab F, Farahzadi R, Charoudeh HNozad. Bone marrow CD34 positive cells may be suitable for collection after death. Transfus Apher Sci. 2022:103452.
Mazloumi Z, Rafat A, Asl KDizaji, Charoudeh HNozad. A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis. Biochem Biophys Res Commun. 2022;640:50-55.
Valipour B, Majidi G, Asl KDizaji, Charoudeh HNozad. Cord blood derived NK cells activated in counter with tumor cells. Cell Tissue Bank. 2022.
2021
Asl KDizaji, Velaei K, Rafat A, Nasrabadi HTayefi, Movassaghpour AAkbar, Mahdavi M, Charoudeh HNozad. The role of KIR positive NK cells in diseases and its importance in clinical intervention. Int Immunopharmacol. 2021;92:107361.